Calpastatin (the Endogenous Calpain Inhibitor) and Membrane Protein Degradation in Cell Fusion
Part of the
Methods in Molecular Biology™
book series (MIMB, volume 144)
Cell membrane fusion is a ubiquitous cellular process, mediating such phenomena as fertilization, muscle development, certain viral infections, and giant cell formation from macrophages. For membrane fusion to occur, the cell membranes must attach to each other, usually by means of interactions between membrane receptors. Increased cellular Ca2+ is required for the various fusion events, and changes occur in the cell membrane and cytoskeleton. Fusion of membranes occurs between the two phospholipid bilayers in regions that are poor in proteins (fusion-potent domains). It has been proposed that membrane protein degradation contributes to the disorganization of cell membrane and cytoskeleton in preparation for the fusion of the cell membranes (1, 2, 3).
KeywordsVortex Glycerol EDTA DMSO Acetonitrile
Yanagimachi R. (1988) Sperm-egg fusion. Curr. Top. Membr. Transp.
, 3–43.Google Scholar
Wakelam M. J. O. (1988) Myoblast fusion: a mechanistic analysis. Curr. Top.Membr. Transp
, 87–112.Google Scholar
Okada Y. (1988) Sendai virus-mediated cell fusion. Curr. Top. Membr. Transp
, 297–336.Google Scholar
Murachi T. (1984) Calcium-dependent proteinase and specific inhibitors: Calpain and calpastatin. Biochem. Soc. Symp
, 149–167.PubMedGoogle Scholar
Ahkong Q. F., Fisher D., Tampion W., and Lucy J. A. (1975) Mechanisms of cell fusion. Nature
, 194–195.PubMedCrossRefGoogle Scholar
Kosower E. M., Kosower N. S., and Wegman P. (1977) Membrane Mobility agents. V: The mechanism of particle-cell and cell-cell fusion. Biochim. Biophys. Acta
, 311–329.PubMedCrossRefGoogle Scholar
Kosower N. S., Glaser T., and Kosower E. M. (1983) Membrane-mobility agent-promoted fusion of erythrocyte: Fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins. Proc. Natl. Acad. Sci. U.S.A
, 7542–7546.PubMedCrossRefGoogle Scholar
Kosower N. S. and Glaser T. (1990) The calpain-calpastatin system and membrane fusion, in Intracellular Calcium-Dependent Proteolysis (Mellgren R. L. and Murachi T., eds.) CRC Press Boca Raton, FL. pp. 163–180.Google Scholar
Barnoy S., Glaser T., and Kosower N.S. (1996) The role of calpastatin (the specifc calpain inhibitor) in myoblast differentiation and fusion. Biochem. Biophys. Res. Commun
, 933–938.PubMedCrossRefGoogle Scholar
Barnoy S., Glaser T., and Kosower N. S. (1997) Calpain and calpastatin in myoblast differentiation and fusion: Effects of inhibitors. Biochim. Biophys. Acta
, 181–188.PubMedCrossRefGoogle Scholar
Barnoy S., Glaser T., and Kosower N. S. (1998) The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochim. Biophys. Acta
, 52–60.PubMedCrossRefGoogle Scholar
Raser K. J., Posner A., and Wang K. K. W. (1995) Casein zymography: A method to study μ-calpain, m-calpain and their inhibitory agents. Arch. Biochem. Biophys
, 211–216.PubMedCrossRefGoogle Scholar
Hayashi M., Saito Y., and Kawashima S. (1992) Calpain activation is essential for membrane fusion of erythrocytes in the presence of exogenous Ca2+
. Biochem. Biophys. Res. Commun
, 939–946.PubMedCrossRefGoogle Scholar
Ross E. and Schatz G. (1973) Assay of protein in the presence of high concentrations of sulfhydryl compounds. Anal. Biochem.
, 304–306.PubMedCrossRefGoogle Scholar
Massague J., Cheifetz S., Endo T., and Nadal-Ginard B. (1986) Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl.Acad. Sci. U.S.A.
, 8206–8210.PubMedCrossRefGoogle Scholar
Schwarz-Benmeir N., Glaser T., Barnoy S., and Kosower N.S. (1994) Calpastatin in erythrocytes of young and old individuals. Biochem. J.
, 365–370.PubMedGoogle Scholar
Glaser T. and Kosower N.S. (1986) Calpain-calpastatin and fusion: Fusibility of erythrocytes is determined by a protease-protease inhibitor (calpain-calpastatin) balance FEBS Lett
, 115–120.PubMedCrossRefGoogle Scholar